Japan Approves Remdesivir for Treatment of COVID-19

Japan Approves Remdesivir for Treatment of COVID-19
Vials of investigational COVID-19 treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, Calif., on March 18, 2020. Gilead Sciences via Reuters
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:
Japanese authorities on Thursday approved remdesivir for treatment of COVID-19, the new disease caused by the CCP (Chinese Communist Party) virus.

Japan’s Ministry of Health, Labour, and Welfare granted regulatory approval to Veklury, or remdesivir.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics